Dr. JianJun Yu is Director of R&D at EffePharm, under his leadership, EffePharm conducted the world's first large-scale human clinical trial of NMN. Graduated from East China University of Science and Technology with a Ph.D. in Applied Chemistry (Doctor of Engineering). Awarded the Second Prize for Natural Science Research by the Ministry of Education. Previously worked at GSK, engaging in antiviral new drug R&D.